116 related articles for article (PubMed ID: 18162612)
1. p38 MAPK inhibition reduces aortic ultrasmall superparamagnetic iron oxide uptake in a mouse model of atherosclerosis: MRI assessment.
Morris JB; Olzinski AR; Bernard RE; Aravindhan K; Mirabile RC; Boyce R; Willette RN; Jucker BM
Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):265-71. PubMed ID: 18162612
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological inhibition of C-C chemokine receptor 2 decreases macrophage infiltration in the aortic root of the human C-C chemokine receptor 2/apolipoprotein E-/- mouse: magnetic resonance imaging assessment.
Olzinski AR; Turner GH; Bernard RE; Karr H; Cornejo CA; Aravindhan K; Hoang B; Ringenberg MA; Qin P; Goodman KB; Willette RN; Macphee CH; Jucker BM; Sehon CA; Gough PJ
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):253-9. PubMed ID: 19965779
[TBL] [Abstract][Full Text] [Related]
3. Assessment of macrophage infiltration in a murine model of abdominal aortic aneurysm.
Turner GH; Olzinski AR; Bernard RE; Aravindhan K; Boyle RJ; Newman MJ; Gardner SD; Willette RN; Gough PJ; Jucker BM
J Magn Reson Imaging; 2009 Aug; 30(2):455-60. PubMed ID: 19629967
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory drug evaluation in ApoE-/- mice by ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Sigovan M; Kaye E; Lancelot E; Corot C; Provost N; Majd Z; Breisse M; Canet-Soulas E
Invest Radiol; 2012 Sep; 47(9):546-52. PubMed ID: 22864378
[TBL] [Abstract][Full Text] [Related]
5. Effects of p38 MAPK Inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production.
Bao W; Behm DJ; Nerurkar SS; Ao Z; Bentley R; Mirabile RC; Johns DG; Woods TN; Doe CP; Coatney RW; Ohlstein JF; Douglas SA; Willette RN; Yue TL
J Cardiovasc Pharmacol; 2007 Jun; 49(6):362-8. PubMed ID: 17577100
[TBL] [Abstract][Full Text] [Related]
6. [Value of in vivo monitoring of abdominal aortic atherosclerosis by high field magnetic resonance imaging in apoE-/- mice fed a high fat diet or infused with angiotensin II].
ZHAO R; YAO YY; DENG G; JU SH; WANG ZJ; WEN S; CHEN J; JIN H
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep; 38(9):823-8. PubMed ID: 21092653
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of ultrasmall superparamagnetic iron-oxide (USPIO) enhanced MRI with ferumoxytol to quantify arterial wall inflammation.
Smits LP; Tiessens F; Zheng KH; Stroes ES; Nederveen AJ; Coolen BF
Atherosclerosis; 2017 Aug; 263():211-218. PubMed ID: 28662398
[TBL] [Abstract][Full Text] [Related]
8. Investigation of atherosclerotic plaques with MRI at 3 T using ultrasmall superparamagnetic particles of iron oxide.
Priest AN; Ittrich H; Jahntz CL; Kooijman H; Weber C; Adam G
Magn Reson Imaging; 2006 Dec; 24(10):1287-93. PubMed ID: 17145399
[TBL] [Abstract][Full Text] [Related]
9. Assessment of age modulated vascular inflammation in ApoE-/- mice by USPIO-enhanced magnetic resonance imaging.
Sigovan M; Bessaad A; Alsaid H; Lancelot E; Corot C; Neyran B; Provost N; Majd Z; Breisse M; Canet-Soulas E
Invest Radiol; 2010 Nov; 45(11):702-7. PubMed ID: 20829703
[TBL] [Abstract][Full Text] [Related]
10. Negative MR contrast caused by USPIO uptake in lymph nodes may lead to false positive observations with in vivo visualization of murine atherosclerotic plaque.
te Boekhorst BC; Bovens SM; Nederhoff MG; van de Kolk KW; Cramer MJ; van Oosterhout MF; Ten Hove M; Doevendans PA; Pasterkamp G; van Echteld CJ
Atherosclerosis; 2010 May; 210(1):122-9. PubMed ID: 19939385
[TBL] [Abstract][Full Text] [Related]
11. Differential uptake of ferumoxtran-10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: critical determinants of atherosclerotic plaque labeling.
Yancy AD; Olzinski AR; Hu TC; Lenhard SC; Aravindhan K; Gruver SM; Jacobs PM; Willette RN; Jucker BM
J Magn Reson Imaging; 2005 Apr; 21(4):432-42. PubMed ID: 15779033
[TBL] [Abstract][Full Text] [Related]
12. Development of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis-targeted ultrasmall superparamagnetic iron oxide derivatives.
Burtea C; Ballet S; Laurent S; Rousseaux O; Dencausse A; Gonzalez W; Port M; Corot C; Vander Elst L; Muller RN
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):e36-48. PubMed ID: 22516067
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of renin-angiotensin system attenuates periadventitial inflammation and reduces atherosclerotic lesion formation.
Fukuda D; Enomoto S; Nagai R; Sata M
Biomed Pharmacother; 2009 Dec; 63(10):754-61. PubMed ID: 19304450
[TBL] [Abstract][Full Text] [Related]
14. Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model.
Sigovan M; Boussel L; Sulaiman A; Sappey-Marinier D; Alsaid H; Desbleds-Mansard C; Ibarrola D; Gamondès D; Corot C; Lancelot E; Raynaud JS; Vives V; Laclédère C; Violas X; Douek PC; Canet-Soulas E
Radiology; 2009 Aug; 252(2):401-9. PubMed ID: 19703881
[TBL] [Abstract][Full Text] [Related]
15. Comparison of contrast agents for atherosclerosis imaging using cultured macrophages: FDG versus ultrasmall superparamagnetic iron oxide.
Satomi T; Ogawa M; Mori I; Ishino S; Kubo K; Magata Y; Nishimoto T
J Nucl Med; 2013 Jun; 54(6):999-1004. PubMed ID: 23670898
[TBL] [Abstract][Full Text] [Related]
16. MRI study of atherosclerotic plaque progression using ultrasmall superparamagnetic iron oxide in Watanabe heritable hyperlipidemic rabbits.
Kaneko C; Nitta N; Tsuchiya K; Watanabe S; Nitta-Seko A; Ohta S; Otani H; Sonoda A; Murata K; Shiomi M
Br J Radiol; 2015 Sep; 88(1053):20150167. PubMed ID: 26083261
[TBL] [Abstract][Full Text] [Related]
17. Scavenger receptor-AI-targeted iron oxide nanoparticles for in vivo MRI detection of atherosclerotic lesions.
Segers FM; den Adel B; Bot I; van der Graaf LM; van der Veer EP; Gonzalez W; Raynal I; de Winther M; Wodzig WK; Poelmann RE; van Berkel TJ; van der Weerd L; Biessen EA
Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1812-9. PubMed ID: 23744990
[TBL] [Abstract][Full Text] [Related]
18. Zoledronate attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of Rho/ROCK-dependent JNK and NF-κB pathway.
Tsai SH; Huang PH; Peng YJ; Chang WC; Tsai HY; Leu HB; Chen JW; Lin SJ
Cardiovasc Res; 2013 Dec; 100(3):501-10. PubMed ID: 24225494
[TBL] [Abstract][Full Text] [Related]
19. Intraperitoneal injection improves the uptake of nanoparticle-labeled high-density lipoprotein to atherosclerotic plaques compared with intravenous injection: a multimodal imaging study in ApoE knockout mice.
Jung C; Kaul MG; Bruns OT; Dučić T; Freund B; Heine M; Reimer R; Meents A; Salmen SC; Weller H; Nielsen P; Adam G; Heeren J; Ittrich H
Circ Cardiovasc Imaging; 2014 Mar; 7(2):303-11. PubMed ID: 24357264
[TBL] [Abstract][Full Text] [Related]
20. In vivo magnetic resonance imaging of atherosclerotic lesions with a newly developed Evans blue-DTPA-gadolinium contrast medium in apolipoprotein-E-deficient mice.
Yasuda S; Ikuta K; Uwatoku T; Oi K; Abe K; Hyodo F; Yoshimitsu K; Sugimura K; Utsumi H; Katayama Y; Shimokawa H
J Vasc Res; 2008; 45(2):123-8. PubMed ID: 17940339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]